Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: A hybrid case-parent triad and case-control study

International Journal of Cancer

Volumn 133, Issue 1, 2013, Pages 201-213

  Hussain, Shehnaz K ^a,b   Madeleine, Margaret M ^c,d   Johnson, Lisa G ^c   Du, Qin ^c   Galloway, Denise A ^c   Daling, Janet R ^c,d   Malkki, Mari ^c   Petersdorf, Effie W ^c   Schwartz, Stephen M ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c USA   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

case parent; Cervical cancer; interleukin 10; interleukin 12; vulvar cancer

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR ALPHA; INTERLEUKIN 10 RECEPTOR BETA; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2;

3' UNTRANSLATED REGION; ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IL-10RA GENE; IL-10RB GENE; IL10 GENE; IL12 GENE; IL12A GENE; IL12RB1 GENE; IL12RB2 GENE; MAJOR CLINICAL STUDY; POPULATION BASED CASE CONTROL STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; VULVA CANCER;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR BETA SUBUNIT; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P35; INTERLEUKIN-12 SUBUNIT P40; MIDDLE AGED; NUCLEOTIDES; ODDS RATIO; PARENTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-10; RECEPTORS, INTERLEUKIN-12; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 84876668389     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28000     Document Type: Article

References (53)

1. Kaufmann AM, Gissmann L, Schneider A,. The Worldwide Perspective on Human Papillomavirus and Cervical Cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 1400-01.
2. Wang SS, Sherman ME, Hildesheim A, et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000. Cancer 2004; 100: 1035-44.
3. Bodelon C, Madeleine MM, Voigt LF, et al. Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes Control 2009; 20: 1779-82.
4. zurHausen H,. Papillomavirus infections-a major cause of human cancers. Biochim Biophys Acta Rev Cancer 1996; 1288: F55-F78.
5. Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997; 89: 1516-23.
6. Hildesheim A, Han CL, Brinton LA, et al. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study. Obstet Gynecol 1997; 90: 748-54.
7. Bais AG, Beckmann I, Lindemans J, et al. A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CINIII lesions. J Clin Pathol 2005; 58: 1096-100.
8. Bermudez-Morales VH, Gutierrez LX, et al. Correlation between IL-10 Gene expression and hpv infection in cervical cancer: a mechanism for immune response escape. Cancer Invest 2008; 26: 1037-43.
9. Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 1997; 89: 245-50.
10. Jacobs N, Giannini SL, Doyen J, et al. Inverse modulation of IL-10 and IL-12 in the blood of women with preneoplastic lesions of the uterine cervix. Clin Exp Immunol 1998; 111: 219-24.
11. Sheu BC, Lin RH, Lien HC, et al. Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 2001; 167: 2972-8.
12. Ivansson EL, Juko-Pecirep I, Erlich HA, et al. Pathway-based analysis of genetic susceptibility to cervical cancer in situ: HLA-DPB1 affects risk in Swedish women. Genes Immun 2011; 12: 605-14.
13. Safaeian M, Hildesheim A, Gonzalez P, et al. Single nucleotide polymorphisms in the PRDX3and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One 2012; 7: e33619.
14. Wang SS, Gonzalez P, Yu K, et al. Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One 2010; 5: e8667.
15. Madeleine MM, Johnson LG, Smith AG, et al. Comprehensive analysis of HLA-A, HLA-B, HLA-C, HLA-DRB1, and HLA-DQB1 loci and squamous cell cervical cancer risk. Cancer Res 2008; 68: 3532-39.
16. Yilmaz V, Yentur SP, Saruhan-Direskeneli G,. IL-12 and IL-10 polymorphisms and their effects on cytokine production. Cytokine 2005; 30: 188-94.
17. Seegers D, Zwiers A, Strober W, et al. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002; 3: 419-23.
18. Rees LE, Wood NA, Gillespie KM, et al. The interleukin-10-1082 G/A polymorphism: allele frequency in different populations and functional significance. Cell Mol Life Sci 2002; 59: 560-9.
19. Turner DM, Williams DM, Sankaran D, et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
20. Epstein MP, Veal CD, Trembath RC, et al. Genetic association analysis using data from triads and unrelated subjects. Am J Hum Genet 2005; 76: 592-608.
21. Daling JR, Madeleine MM, McKnight B, et al. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection. Cancer Epidemiol Biomarkers Prev 1996; 5: 541-8.
22. Hankey BF, Ries LA, Edwards BK,. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev 1999; 8: 1117-21.
23. Harlow BL, Davis S,. Two one-step methods for household screening and interviewing using random digit dialing. Am J Epidemiol 1988; 127: 857-63.
24. Seattle SNPs. NHLBI program for genomic applications. Seattle, WA: UW-FHCRC. Available at: http://pga.gs.washington.edu. Last accessed August, 2003.
25. Altshuler D, Brooks LD, Chakravarti A, et al. A haplotype map of the human genome. Nature 2005; 437: 1299-320.
26. de Bakker PI, Yelensky R, Pe'er I, et al. Efficiency and power in genetic association studies. Nat Genet 2005; 37: 1217-23.
27. Edlund CK, Lee WH, Li DL, et al. Snagger: a user-friendly program for incorporating additional information for tagSNP selection. BMC Bioinformatics 2008; 9.
28. Resnick RM, Cornelissen MTE, Wright DK, et al. Detection and typing of human papillomavirus in archival cervical-cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477-84.
29. Hsu L, Starr JR, Zhen YY, et al. On combining triads and unrelated subjects data in candidate gene studies: an application to data on testicular cancer. Hum Hered 2009; 67: 88-103.
30. Holm S,. A simple sequentially rejective multipletest procedure. Scand J Statist 1979; 6: 65-70.
31. Gubler U, Chua AO, Schoenhaut DS, et al. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 1991; 88: 4143-7.
32. Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-90.
33. Morris GAJ, Edwards DRV, Hill PC, et al. Interleukin 12B (IL12B) genetic variation and pulmonary tuberculosis: a study of cohorts from The Gambia, Guinea-Bissau, United States and Argentina. PLoS ONE 6 (2): e16656. doi: 10.1371/journal.pone.0016656.
34. Yin LM, Zhu WF, Wei L, et al. Association of interleukin-12 p40 gene 3'-untranslated region polymorphism and outcome of HCV infection. World J Gastroenterol 2004; 10: 2330-33.
35. Tamandani DMK, Shekari M, Suri V,. Interleukin-12 gene polymorphism and cervical cancer risk. Am J Clin Oncol 2009; 32: 524-28.
36. Chen XJ, Han SP, Wang SN, et al. Interactions of IL-12A and IL-12B polymorphisms on the risk of cervical cancer in chinese women. Clin Cancer Res 2009; 15: 400-05.
37. Han SS, Cho EY, Lee TS, et al. Interleukin-12 p40 gene (IL12B) polymorphisms and the risk of cervical caner in Korean women. Eur J Obstet Gynecol Reprod Biol 2008; 140: 71-75.
38. Png E, Alisjahbana B, Sahiratmadja E, et al. A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians. BMC Med Genet 2012; 13: 5.
39. Ng PC, Henikoff S,. Predicting deleterious amino acid substitutions. Genome Res 2001; 11: 863-74.
40. Ramensky V, Bork P, Sunyaev S,. Human non-synonymous SNPs: server and survey. Nucleic Acids Res 2002; 30: 3894-900.
41. Akahoshi M, Nakashima H, Miyake K, et al. Influence of interleukin-12 receptor beta1 polymorphisms on tuberculosis. Hum Genet 2003; 112: 237-43.
42. Arany I, Grattendick KG, Tyring SK,. Interleukin-10 induces transcription of the early promoter of human papillomavirus type 16 (HPV16) through the 5'-segment of the upstream regulatory region (URR). Antiviral Res 2002; 55: 331-9.
43. Simhan HN, Ryckman KK, Williams SM, et al. Genetic regulation of cervical antiinflammatory cytokine concentrations during pregnancy. Am J Obstet Gynecol 2008; 199: 163.e1-163.e11.
44. Shrestha S, Wang C, Aissani B, et al. Interleukin-10 gene (IL10) polymorphisms and human papillomavirus clearance among immunosuppressed adolescents. Cancer Epidemiol Biomarkers Prev 2007; 16: 1626-32.
45. Zoodsma M, Nolte IM, Schipper M, et al. Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer 2005; 15(Suppl 3): 282-90.
46. Stanczuk GA, Sibanda EN, Perrey C, et al. Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int J Cancer 2001; 94: 792-4.
47. Ivansson EL, Gustavsson IM, Magnusson JJ, et al. Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer. Int J Cancer 2007; 121: 2451-57.
48. Roh JW, Kim MH, Seo SS, et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett 2002; 184: 57-63.
49. Madeleine MM, Daling JR, Carter JJ, et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997; 89: 1516-23.
50. Srodon M, Stoler MH, Baber GB, et al. The distribution of low and high-risk HPV types in culvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol 2006; 30: 1513-18.
51. de Gonzalez AB, Sweetland S, Green J,. Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis. Br J Cancer 2004; 90: 1787-91.
52. Farley J, Gray K, Nycum L, et al. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1). Gynecol Oncol 2000; 78: 113-22.
53. Davidson EJ, Davidson JA, Sterling JC, et al. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res 2003; 63: 400-03.